Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
119M
-
Shares change
-
+27.7M
-
Total reported value, excl. options
-
$1.05B
-
Value change
-
+$237M
-
Put/Call ratio
-
0.41
-
Number of buys
-
92
-
Number of sells
-
-50
-
Price
-
$8.85
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q4 2018
161 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q4 2018.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 119M shares
of 334M outstanding shares and own 35.46% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (12.2M shares), venBio Select Advisor LLC (10.3M shares), BlackRock Inc. (8.78M shares), FRANKLIN RESOURCES INC (8.28M shares), Broadfin Capital, LLC (5.95M shares), Vanguard Group Inc (5.78M shares), FARALLON CAPITAL MANAGEMENT LLC (5.73M shares), GREAT POINT PARTNERS LLC (5.57M shares), ORBIMED ADVISORS LLC (5.55M shares), and STATE STREET CORP (4.48M shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.